Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed cases of diabetes. 2. Individuals who provide informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Individuals with type 1 diabetes. 2. Individuals with peripheral arterial disease. 3. Pregnant women and Individuals with other pre-existing conditions affecting peripheral nerves. 4. Individuals on any medication that may adversely influence peripheral nerve function 5. Participants who are unable or unwilling to provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected outcome of the study is to validate the newly developed device to detect diabetic neuropathy and enable early detection even in its initial stage, improving access to affordable and convenient screening particularly in underserved or resource limited areas. It is expected to prove a user friendly, practical and feasible point of care use in community and field settings providing alternate to traditional diagnosis.Timepoint: one time assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| The study seeks to contribute to the development of scalable screening programs & healthcare policies targeting the low resource setting to reduce the burden on healthcare system & improve community health.Timepoint: one time assessment | — |
Countries
India
Contacts
Saveetha Medical College And Hospital, Chennai